“Appropriate Utilization of the Prognostic 40-Gene Expression Profile (40-GEP) Test for Cutaneous Squamous Cell Carcinoma (cSCC) Demonstrated by Clinical Reports and Physician Evaluation of Real-World Cases”. 2022. SKIN The Journal of Cutaneous Medicine 6 (2): s21. https://doi.org/10.25251/skin.6.supp.21.